Picture of Ocugen logo

OCGN Ocugen Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for Ocugen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-20.2-21.8-58.4-81.4-63.1
Depreciation
Non-Cash Items6.48.227.7611.613.5
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-3.11-1.212.449.2-13.2
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-16.9-14.7-47.9-60.1-62.1
Capital Expenditures-0.029-0.307-1.07-4.46-10.5
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-2.330-0.75-12.513.6
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2.36-0.307-1.82-173.08
Financing Cash Flow Items-0.173-1.48-8.53-0.592-0.423
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities25.131.612159.520.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash5.8216.670.9-17.5-38.1